| 智富资源投资 |
Hong Kong Finance Equity Holding Limited (Formerly known as Hoifu Group Investment Holdings Limited) |
减持 |
-184408000 |
43151.71万股 |
0.11% |
好仓 |
2020-11-03 |
| 智富资源投资 |
许智铭 |
增持 |
53226000 |
219897.45万股 |
0.55% |
好仓 |
2020-11-03 |
| 智富资源投资 |
许智铭 |
减持 |
-184408000 |
214574.85万股 |
0.54% |
好仓 |
2020-11-03 |
| QPL INT'L |
许秀琼 |
增持 |
37600000 |
3760.00万股 |
0.20% |
好仓 |
2020-11-03 |
| 药明巨诺-B |
CPE Holdings Limited |
增持 |
19552250 |
1955.22万股 |
0.05% |
好仓 |
2020-11-03 |
| 药明巨诺-B |
CPE Funds III Limited |
增持 |
19552250 |
1955.22万股 |
0.05% |
好仓 |
2020-11-03 |
| 药明巨诺-B |
CPEChina Fund III, L.P. |
增持 |
19552250 |
1955.22万股 |
0.05% |
好仓 |
2020-11-03 |
| 药明巨诺-B |
CJW Therapeutics Investment Limited |
增持 |
19552250 |
1955.22万股 |
0.05% |
好仓 |
2020-11-03 |
| 智富资源投资 |
许智铭 |
减持 |
-184408000 |
214549.05万股 |
0.54% |
好仓 |
2020-11-03 |
| 智富资源投资 |
许智铭 |
增持 |
53226000 |
219871.65万股 |
0.55% |
好仓 |
2020-11-03 |
| 智富资源投资 |
许智铭 |
增持 |
53226000 |
219871.65万股 |
0.55% |
好仓 |
2020-11-03 |
| 华盛国际控股 |
符史圣 |
减持 |
-66037735 |
11233.96万股 |
0.03% |
好仓 |
2020-11-03 |
| 药明巨诺-B |
Syracuse Biopharma (Cayman) Ltd. |
增持 |
48513377 |
4851.34万股 |
0.13% |
好仓 |
2020-11-03 |
| 智富资源投资 |
Hong Kong Finance Equity Holding Limited (Formerly known as Hoifu Group Investment Holdings Limited) |
增持 |
53226000 |
48474.31万股 |
0.12% |
好仓 |
2020-11-03 |
| 药明巨诺-B |
TLS Beta Pte. Ltd. |
增持 |
22668740 |
2266.87万股 |
0.06% |
好仓 |
2020-11-03 |
| 药明巨诺-B |
Temasek Life Sciences Private Limited |
增持 |
22668740 |
2266.87万股 |
0.06% |
好仓 |
2020-11-03 |
| 药明巨诺-B |
李丹 |
增持 |
21795080 |
2179.51万股 |
0.06% |
好仓 |
2020-11-03 |
| 药明巨诺-B |
WuXi AppTec (Hong Kong) Holding Limited |
增持 |
38232570 |
3823.26万股 |
0.10% |
好仓 |
2020-11-03 |
| 药明巨诺-B |
WuXi AppTec (Shanghai) Co., Ltd. (上海药明康德新药开发有限公司) |
增持 |
38232570 |
3823.26万股 |
0.10% |
好仓 |
2020-11-03 |
| 药明巨诺-B |
WuXi AppTec Co., Ltd. |
增持 |
38232570 |
3823.26万股 |
0.10% |
好仓 |
2020-11-03 |
